[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@BioCentury BioCentury
BioCentury posts on X about novartis, jacob, $googl the most. They currently have XXXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXXX +3,524%
- X Month XXXXXXX +804%
- X Months XXXXXXX +89%
- X Year XXXXXXX +18%
Mentions: X #
- X Week XX +9.10%
- X Month XX +6.90%
- X Months XXX +1.60%
- X Year XXX -XXXX%
Followers: XXXXXX #
- X Week XXXXXX +0.56%
- X Month XXXXXX +0.87%
- X Months XXXXXX +1.70%
- X Year XXXXXX +2.80%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence stocks XXXX% finance XXXX% technology brands XXXX%
Social topic influence novartis 1.56%, jacob 1.56%, $googl XXXX%
Top accounts mentioned or mentioned by @jeff_cranmer @sofinnovavcs @nvidia @usfdas @usfda @cincorpharma @albireopharma @wuxiapptec @wuxibiologics @seemacms @scottgottliebmd @pfizer @biopharmajosh @nociftw @cbtadvisors @flyingeagle86 @lcccc333 @marketwirenews @fishburnsimone @akesoinc
Top assets mentioned Novartis AG (NVS) Alphabet Inc Class A (GOOGL)
Top Social Posts #
Top posts by engagements in the last XX hours
"Rare disease setbacks for Ultragenyx mid-stage win for Rhythm. Plus: Astrazeneca and Takeda preparing submissions after Phase III readouts in this weeks Clinical Report"
@BioCentury on X 2025-07-15 22:30:12 UTC 16.3K followers, XXX engagements
"Third patient dies from acute liver failure caused by a Sarepta gene therapy" @BioCentury on X 2025-07-18 00:00:08 UTC 16.3K followers, 92.9K engagements
"BioCentury's latest biopharma Management Moves: Steve Bates longtime head of BIA named executive chair of U.K.s Office of Life Sciences. Plus: Novartis names Mazuk chief patient experience officer and updates from Seres and ABPI" @BioCentury on X 2025-07-22 22:30:04 UTC 16.3K followers, XXX engagements
"Lundbeckfondens Jacob Falck Hansen becomes CEO of portfolio company Vesper Bio. Also in BioCentury's Management Moves Column:Oncolytics reunitesAromando with new CEO Kelly and updates fromGalderma JadeOutlookAvacta andZura" @BioCentury on X 2025-07-02 01:30:08 UTC 16.3K followers, XXX engagements
"BioCentury's latest management tracks: Stumpe an alum of Tempus and Google named chief tech officer at Danaher. Plus: Updates from Cardiff Regenics X-chem" @BioCentury on X 2025-06-28 00:30:09 UTC 16.3K followers, XXX engagements